México Mercado de Dispositivos de Cardiología Intervencionista Tamaño, Participación, Tendencias y Pronóstico por Producto, Usuario Final y Región, 2026-2034

Overview of the interventional cardiology devices market in Mexico:

The interventional cardiology devices market in Mexico reached USD 391.7 million in 2025. Looking ahead, IMARC Group expects the market to reach USD 676.0 million by 2034 , exhibiting a compound annual growth rate (CAGR) of 6.06% during 2026-2034 .  The market is growing steadily, driven by the increasing prevalence of cardiovascular diseases (CVDs) and the growing adoption of minimally invasive procedures. Technological advancements and the expansion of healthcare infrastructure are further supporting market development. Strong demand for innovative stents, catheters, and guidewires is shaping product trends. Increasing awareness and improved patient access to specialized treatments are enhancing the growth outlook and maintaining a significant market share for interventional cardiology devices in Mexico.

Market trends for interventional cardiology devices in Mexico:

Growing demand for accessories

In Mexico, the growing interest in minimally invasive cardiovascular (MI) procedures has significantly boosted the demand for accessory devices such as guidewires, catheters, and introducer sheaths. These tools play a fundamental role in the accuracy and safety of interventional cardiology techniques. Physicians increasingly prefer procedures that reduce recovery time, complications, and hospital stays, all supported by these advanced accessories. The shift toward high-performance, user-friendly devices has encouraged manufacturers to invest in innovative designs. Hospitals and specialized clinics are also upgrading their inventory of these tools to adapt to advancements in procedures. This trend is expected to intensify as medical professionals seek greater control over procedures and improved patient outcomes by utilizing supportive technologies in cardiology.

The preference for coronary stents continues

Coronary stents remain a mainstay of interventional cardiology procedures in Mexico due to their critical role in securing blocked or obstructed arteries. Cardiologists have long used them extensively to open blood vessels during procedures such as angioplasty. Technological advancements in stent materials and designs over the years have made these devices safer and more effective, increasing their popularity. Mexican healthcare professionals tend to favor stents that reduce the risk of restenosis and improve long-term outcomes. Furthermore, the aging population and the rise in lifestyle-related heart disease continue to drive demand for stent-based treatments. Consequently, coronary stents are expected to continue dominating the growth of the Mexican interventional cardiology device market.

Strong regulatory influence of COFEPRIS

The market for interventional cardiology devices in Mexico is heavily influenced by the Mexican regulatory authority, COFEPRIS. This organization mandates that medical devices must be safe, of good quality, and effective before they are permitted on the market. Manufacturers must comply with these regulations to obtain approval and gain the trust of healthcare professionals. COFEPRIS fosters an environment that promotes regulatory compliance and innovation, challenging companies to maintain high standards while introducing new technologies. The rigorous approval process ensures that only reliable and safe devices are used in procedures. In this way, the regulatory environment not only protects public health but also facilitates long-term market stability and growth in the field of interventional cardiology.

Market segmentation of interventional cardiology devices in Mexico:

IMARC Group offers an analysis of key trends in each market segment, along with national and regional forecasts for 2026-2034. Our report has categorized the market based on product and end user.

Product Perspectives:

• Stents
  • Drug-eluting stents
  • Uncoated metal stents
  • Stents bioabsorbibles
• Interventional catheters
  • IVUS catheters
  • Guide catheters
  • Angiography catheters
• PTCA Guides
• Balloon inflator device
• PTCA Balls
  • Cut balloons
  • Score balloons
  • Drug-eluting balloons
  • Regular balloons 

The report offers a detailed breakdown and analysis of the market by product. This includes stents (drug-eluting stents, uncoated metallic stents, and bioabsorbable stents), interventional catheters (IVUS catheters, guide catheters, and angiography catheters), PCI guidewires, balloon inflation devices, and PCI balloons (cutting balloons, puncture balloons, drug-eluting balloons, and standard balloons).

End-user perspectives:

• Hospitals
• Outpatient surgical centers
• Others

The report also provides a detailed breakdown and analysis of the market based on end user. This includes hospitals, outpatient surgical centers, and others.

Regional perspectives:

• Northern Mexico
• Central Mexico
• Southern Mexico
• Others

The report also provided a comprehensive analysis of key regional markets, including northern, central, and southern Mexico, among others.

Competitive landscape:

The market research report also provides a comprehensive analysis of the competitive landscape. This includes competitive analysis such as market structure, key player positioning, leading winning strategies, a competitive dashboard, and a company assessment quadrant. Detailed profiles of the top companies are also provided.

Noticias del mercado de dispositivos de cardiología intervencionista en México:

• En marzo de 2025, Boston Scientific ha anunciado un acuerdo para adquirir SoniVie Ltd., empresa de dispositivos médicos conocida por el sistema de ultrasonidos intravasculares TIVUS. El sistema TIVUS está diseñado para la terapia de denervación renal y ofrece un tratamiento mínimamente invasivo de la hipertensión mediante la actuación sobre los nervios que rodean los vasos sanguíneos. Esta adquisición amplía la cartera de productos de cardiología intervencionista de Boston Scientific y respalda los avances en curso en el tratamiento de la hipertensión, con los resultados positivos de los ensayos clínicos ya comunicados para el sistema TIVUS.
• En diciembre de 2024, SMT (Sahajanand Medical Technologies) lanzó en México su sistema Hydra de sustitución transcatéter de la válvula aórtica (TAVR), ampliando así su alcance mundial. El sistema ofrece características innovadoras como marcadores de marco, un diseño supraanular y un marco flexible para un reemplazo valvular aórtico preciso, seguro y eficaz. Aprobado por la COFEPRIS, Hydra responde a la creciente demanda de atención cardiaca avanzada en México. La estrategia de expansión de SMT incluye más de 20 países, lo que mejora el acceso global a soluciones cardiovasculares de alta calidad.

Cobertura del informe sobre el mercado de dispositivos de cardiología intervencionista en México:

Preguntas clave respondidas en este informe:

• ¿Cómo se ha comportado hasta ahora el mercado mexicano de dispositivos de cardiología intervencionista y cómo se comportará en los próximos años?
• ¿Cuál es el desglose del mercado mexicano de dispositivos de cardiología intervencionista por producto?
• What is the breakdown of the Mexican market for interventional cardiology devices based on the end user?
• What is the breakdown of the Mexican market for interventional cardiology devices by region?
• What are the different stages of the value chain in the interventional cardiology device market in Mexico?
• What are the main driving factors and challenges in the interventional cardiology device sector in Mexico?
• What is the structure of the Mexican market for interventional cardiology devices and who are its main players?
• What is the level of competition in the Mexican market for interventional cardiology devices?

Main benefits for stakeholders:

• The IMARC industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and market dynamics for interventional cardiology devices in Mexico from 2020-2034.
• The research report provides the latest information on market drivers, challenges, and opportunities in the interventional cardiology devices market in Mexico.
• Porter's Five Forces analysis helps stakeholders assess the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders analyze the level of competition within the interventional cardiology device industry in Mexico and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of the major market players.